Anne‐Sophie Ribba

1.6k total citations
52 papers, 1.2k citations indexed

About

Anne‐Sophie Ribba is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Anne‐Sophie Ribba has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 14 papers in Genetics and 13 papers in Immunology. Recurrent topics in Anne‐Sophie Ribba's work include Platelet Disorders and Treatments (41 papers), Blood groups and transfusion (23 papers) and Blood disorders and treatments (14 papers). Anne‐Sophie Ribba is often cited by papers focused on Platelet Disorders and Treatments (41 papers), Blood groups and transfusion (23 papers) and Blood disorders and treatments (14 papers). Anne‐Sophie Ribba collaborates with scholars based in France, United States and Switzerland. Anne‐Sophie Ribba's co-authors include Dominique Meyer, Geneviève Piétu, Claudine Mazurier, Bernadette Obert, Dominique Meyer, E Fressinaud, Lysiane Hilbert, Jean‐Pierre Girma, Chantal Loirat and Ghislaine Chérel and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Anne‐Sophie Ribba

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne‐Sophie Ribba France 20 867 385 207 148 145 52 1.2k
Dominique Bluteau France 19 714 0.8× 191 0.5× 168 0.8× 319 2.2× 38 0.3× 22 1.3k
Marloes R. Tijssen United Kingdom 16 430 0.5× 143 0.4× 120 0.6× 166 1.1× 40 0.3× 29 852
Sebastian Dütting Germany 12 360 0.4× 179 0.5× 44 0.2× 75 0.5× 75 0.5× 18 846
Larissa Lordier France 14 428 0.5× 74 0.2× 57 0.3× 141 1.0× 52 0.4× 21 788
T Papayannopoulou United States 18 641 0.7× 239 0.6× 181 0.9× 403 2.7× 49 0.3× 54 1.4k
Angelika M. Dräger Netherlands 13 323 0.4× 261 0.7× 47 0.2× 125 0.8× 49 0.3× 22 784
June D. Wencel-Drake United States 12 547 0.6× 123 0.3× 49 0.2× 52 0.4× 108 0.7× 13 904
Nel R. Blom Netherlands 11 405 0.5× 96 0.2× 32 0.2× 122 0.8× 56 0.4× 22 600
Nagaharu Tsukiji Japan 16 207 0.2× 151 0.4× 40 0.2× 47 0.3× 83 0.6× 29 665

Countries citing papers authored by Anne‐Sophie Ribba

Since Specialization
Citations

This map shows the geographic impact of Anne‐Sophie Ribba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Sophie Ribba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Sophie Ribba more than expected).

Fields of papers citing papers by Anne‐Sophie Ribba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Sophie Ribba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Sophie Ribba. The network helps show where Anne‐Sophie Ribba may publish in the future.

Co-authorship network of co-authors of Anne‐Sophie Ribba

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Sophie Ribba. A scholar is included among the top collaborators of Anne‐Sophie Ribba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Sophie Ribba. Anne‐Sophie Ribba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grichine, Alexeï, Shancy Jacob, Anita Eckly, et al.. (2023). The fate of mitochondria during platelet activation. Blood Advances. 7(20). 6290–6302. 13 indexed citations
2.
Sadoul, Karin, et al.. (2018). Déchiffrage du code tubuline. médecine/sciences. 34(12). 1047–1055. 5 indexed citations
3.
Brunner, Molly, Thierry Gautier, Geneviève Chevalier, et al.. (2018). β1 integrins mediate the BMP2 dependent transcriptional control of osteoblast differentiation and osteogenesis. PLoS ONE. 13(4). e0196021–e0196021. 26 indexed citations
4.
Brunner, Molly, Vinay Mandati, Bernhard Wehrle‐Haller, et al.. (2017). β1 integrin–dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin. Journal of Biological Chemistry. 292(47). 19179–19197. 92 indexed citations
5.
Bouin, Anne‐Pascale, Anne‐Sophie Ribba, Eva Faurobert, et al.. (2017). ICAP-1 monoubiquitylation coordinates matrix density and rigidity sensing for cell migration through ROCK2–MRCKα balance. Journal of Cell Science. 130(3). 626–636. 7 indexed citations
6.
Millon‐Frémillon, Angélique, Molly Brunner, Nadia Abed, et al.. (2013). Calcium and Calmodulin-dependent Serine/Threonine Protein Kinase Type II (CaMKII)-mediated Intramolecular Opening of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP-1α) Negatively Regulates β1 Integrins. Journal of Biological Chemistry. 288(28). 20248–20260. 18 indexed citations
7.
Rayes, Julie, Paulette Legendre, Agnès Veyradier, et al.. (2007). Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS‐13. Journal of Thrombosis and Haemostasis. 5(2). 321–328. 38 indexed citations
8.
Veyradier, Agnès, Chantal Loirat, Jean‐Pierre Girma, et al.. (2005). Purpura thrombotique thrombocytopénique par déficit héréditaire en ADAMTS13 (syndrome d’Upshaw-Schulman) : actualités et perspectives. Hématologie. 11(5). 321–334. 3 indexed citations
9.
Stépanian, Alain, E Fressinaud, Claudine Mazurier, et al.. (2005). Mutations C1157F and C1234W of von Willebrand factor cause intracellular retention with defective multimerization and secretion. Journal of Thrombosis and Haemostasis. 4(1). 148–157. 19 indexed citations
10.
Stépanian, Alain, Anne‐Sophie Ribba, Jean‐Maurice Lavergne, et al.. (2003). A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease. British Journal of Haematology. 120(4). 643–651. 15 indexed citations
11.
Villoutreix, Bruno O., et al.. (2002). Two Clusters of Charged Residues Located in the Electropositive Face of the Von Willebrand Factor A1 Domain Are Essential for Heparin Binding. Biochemistry. 41(21). 6668–6678. 21 indexed citations
12.
Ribba, Anne‐Sophie, et al.. (2002). Identification of a New Type 2M von Willebrand Disease Mutation also at Position 1324 of von Willebrand Factor. Thrombosis and Haemostasis. 87(4). 635–640. 12 indexed citations
13.
Meyer, Dominique, E Fressinaud, Lysiane Hilbert, et al.. (2001). Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function. Best Practice & Research Clinical Haematology. 14(2). 349–364. 28 indexed citations
14.
15.
Ribba, Anne‐Sophie, et al.. (2000). Regulated von Willebrand factor (vWf) secretion is restored by pro-vWf expression in a transfectable endothelial cell line. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1495(1). 112–119. 10 indexed citations
16.
Siguret, Virginie, Anne‐Sophie Ribba, & Dominique Meyer. (1998). [Biological diagnosis of Willebrand disease].. PubMed. 55(6). 601–6.
17.
Ribba, Anne‐Sophie, Jean‐Maurice Lavergne, Jean‐Pierre Girma, & Dominique Meyer. (1995). Bases moléculaires de la maladie de Willebrand. Hématologie. 1(3). 1 indexed citations
18.
Ribba, Anne‐Sophie, et al.. (1994). Effect of plasmid size on transformation efficiency by electroporation of Escherichia coli DH5 alpha.. PubMed. 16(3). 422–6. 17 indexed citations
19.
Piétu, Geneviève, et al.. (1992). Molecular study of von Willebrand disease. Blood Coagulation & Fibrinolysis. 3(4). 415–421. 9 indexed citations
20.
Piétu, Geneviève, Anne‐Sophie Ribba, Pierre Meulien, & Dominique Meyer. (1989). Localization within the 106 N-terminal amino acids of von Willebrand Factor (vWF) of the epitope corresponding to a monoclonal antibody which inhibits vWF binding to factor VIII. Biochemical and Biophysical Research Communications. 163(1). 618–626. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominique Bluteau Breakdown of academic impact, for papers by Marloes R. Tijssen Breakdown of academic impact, for papers by Sebastian Dütting Breakdown of academic impact, for papers by Larissa Lordier Breakdown of academic impact, for papers by T Papayannopoulou Breakdown of academic impact, for papers by Angelika M. Dräger Breakdown of academic impact, for papers by June D. Wencel-Drake Breakdown of academic impact, for papers by Nel R. Blom Breakdown of academic impact, for papers by Nagaharu Tsukiji
Rankless by CCL
2026